Bionano Genomics Sees Q3 Sales $8.200M-$8.600M vs $8.575M Est

Benzinga Newsdesk www.benzinga.com Positive 75.8%

Neg 0% Neu 0% Pos 75.8%

Bionano Genomics (NASDAQ:BNGO) sees Q3 sales of $8.200 million-$8.600 million vs $8.575 million analyst estimate.

Comments

No comments yet. Be the first!